{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T06:34:40Z","timestamp":1791441280529,"version":"4.3.3"},"reference-count":33,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2004,5,1]],"date-time":"2004-05-01T00:00:00Z","timestamp":1083369600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Journal of Pediatrics"],"published-print":{"date-parts":[[2004,5]]},"DOI":"10.1016\/j.jpeds.2004.01.046","type":"journal-article","created":{"date-parts":[[2004,5,12]],"date-time":"2004-05-12T10:26:10Z","timestamp":1084357570000},"page":"581-588","source":"Crossref","is-referenced-by-count":483,"title":["Enzyme replacement therapy for mucopolysaccharidosis I: a randomized, double-blinded, placebo-controlled, multinational study of recombinant human \u03b1-L-iduronidase (laronidase)"],"prefix":"10.1016","volume":"144","author":[{"given":"James E","family":"Wraith","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorne A","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Beck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edwin H","family":"Kolodny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory M","family":"Pastores","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Muenzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M","family":"Rapoport","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth I","family":"Berger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart J","family":"Swiedler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emil D","family":"Kakkis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanja","family":"Braakman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elenie","family":"Chadbourne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Walton-Bowen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald F","family":"Cox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpeds.2004.01.046_BIB1","series-title":"The metabolic and molecular bases of inherited diseases","first-page":"3421","article-title":"The mucopolysaccharidoses","author":"Neufeld","year":"2001"},{"key":"10.1016\/j.jpeds.2004.01.046_BIB2","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.1440-1673.1986.tb02408.x","article-title":"A further contribution to the knowledge of mucopolysaccharidosis I H\/S compound: presentation of two cases and review of the literature","volume":"30","author":"Colavita","year":"1986","journal-title":"Australas Radiol"},{"key":"10.1016\/j.jpeds.2004.01.046_BIB3","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1002\/ajmg.1320200308","article-title":"The clinical spectrum of \u03b1-L-iduronidase deficiency","volume":"20","author":"Roubicek","year":"1985","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.jpeds.2004.01.046_BIB4","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0022-3476(98)70201-X","article-title":"Follow-up of nine patients with Hurler syndrome after bone marrow transplantation","volume":"133","author":"Guffon","year":"1998","journal-title":"J Pediatr"},{"key":"10.1016\/j.jpeds.2004.01.046_BIB5","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1182\/blood.V91.7.2601","article-title":"Hurler syndrome,","volume":"91","author":"Peters","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.jpeds.2004.01.046_BIB6","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1136\/adc.76.2.92","article-title":"Bone marrow transplantation for mucopolysaccharidosis type I: experience of two British centres","volume":"76","author":"Vellodi","year":"1997","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.jpeds.2004.01.046_BIB7","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/ajmg.1320460222","article-title":"Long-term outcome of Hurler syndrome following bone marrow transplantation","volume":"46","author":"Whitley","year":"1993","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.jpeds.2004.01.046_BIB8","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1023\/A:1010379320378","article-title":"Enzyme replacement therapy in mucopolysaccharidosis type I: progress and emerging difficulties","volume":"24","author":"Wraith","year":"2001","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.jpeds.2004.01.046_BIB9","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1006\/bmme.1996.0044","article-title":"Long-term and high dose trials of enzyme replacement therapy in the canine model of mucopolysaccharidosis I","volume":"58","author":"Kakkis","year":"1996","journal-title":"Biochem Mol Med"},{"key":"10.1016\/j.jpeds.2004.01.046_BIB10","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1006\/mgme.2000.3140","article-title":"Enzyme expression replacement therapy in feline mucopolysaccharidosis I","volume":"72","author":"Kakkis","year":"2001","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.jpeds.2004.01.046_BIB11","doi-asserted-by":"crossref","first-page":"12937","DOI":"10.1073\/pnas.91.26.12937","article-title":"Enzyme replacement in a canine model of Hurler syndrome","volume":"91","author":"Shull","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jpeds.2004.01.046_BIB12","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1056\/NEJM200101183440304","article-title":"Enzyme-replacement therapy in mucopolysccharidosis I","volume":"344","author":"Kakkis","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jpeds.2004.01.046_BIB13","series-title":"Pulmonary function testing in children: techniques and standards","author":"Polgar","year":"1971"},{"key":"10.1016\/j.jpeds.2004.01.046_BIB14","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1164\/ajrccm.152.3.7663792","article-title":"Standardization of Spirometry, 1994 Update","volume":"152","author":"American Thoracic Society","year":"1995","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jpeds.2004.01.046_BIB15","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1164\/ajrccm.159.1.9712108","article-title":"Spirometric reference values from a sample of the general US population","volume":"159","author":"Hankinson","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jpeds.2004.01.046_BIB16","first-page":"1175","article-title":"Detection of respiratory events during NPSG: nasal cannula\/pressure sensor versus thermistor","volume":"20","author":"Norman","year":"1997","journal-title":"Sleep"},{"key":"10.1016\/j.jpeds.2004.01.046_BIB17","series-title":"A manual of standardized terminology, techniques, and scoring system for sleep states of human subjects","author":"Rechtschaffen","year":"1968"},{"key":"10.1016\/j.jpeds.2004.01.046_BIB18","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1164\/ajrccm.163.2.9808132","article-title":"Classification of sleep disordered breathing","volume":"163","author":"Hosselet","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jpeds.2004.01.046_BIB19","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1093\/sleep\/24.8.937","article-title":"Feasibility of using unattended polysomnography in children for research: report of the Tucson Children's Assessment of Sleep Apnea study (TuCASA)","volume":"24","author":"Goodwin","year":"2001","journal-title":"Sleep"},{"key":"10.1016\/j.jpeds.2004.01.046_BIB20","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/art.1790050303","article-title":"The health assessment questionnaire 1992: status and review","volume":"3","author":"Ramey","year":"1992","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.jpeds.2004.01.046_BIB21","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1002\/art.1780371209","article-title":"Measurement of health status in children with juvenile rheumatoid arthritis","volume":"37","author":"Singh","year":"1994","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jpeds.2004.01.046_BIB22","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1164\/ajrccm\/144.5.1202","article-title":"Lung function testing: selection of reference values and interpretative strategies","volume":"144","author":"American Thoracic Society","year":"1991","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.jpeds.2004.01.046_BIB23","unstructured":"Serevent Diskus (salmeterol xinafoate inhalation powder) US package insert. Glaxo SmithKline, Research Triangle Park, North Carolina, 27709, August 2003."},{"key":"10.1016\/j.jpeds.2004.01.046_BIB24","unstructured":"Singulair (montelukast sodium) US package insert. Merck & Co, Inc, Whitehouse Station, New Jersey 08889, May 2003."},{"key":"10.1016\/j.jpeds.2004.01.046_BIB25","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1056\/NEJM199409083311003","article-title":"Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis: the Pulmozyme Study Group","volume":"331","author":"Fuchs","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jpeds.2004.01.046_BIB26","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1378\/chest.110.4.889","article-title":"Effects of 12-week administration of dornase alfa in patients with advanced cystic fibrosis lung disease. Pulmozyme Study Group","volume":"110","author":"McCoy","year":"1996","journal-title":"Chest"},{"key":"10.1016\/j.jpeds.2004.01.046_BIB27","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1093\/ptj\/68.9.1371","article-title":"Functional ambulation velocity and distance requirements in rural and urban communities: a clinical report","volume":"68","author":"Robinett","year":"1988","journal-title":"Phys Ther"},{"key":"10.1016\/j.jpeds.2004.01.046_BIB28","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1164\/ajrccm.158.5.9710086","article-title":"Reference equations for the six-minute walk in healthy adults","volume":"158","author":"Enright","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jpeds.2004.01.046_BIB29","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1164\/ajrccm.155.4.9105067","article-title":"Interpreting small differences in functional status: the Six-Minute Walk test in chronic lung disease patients","volume":"155","author":"Redelmeier","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jpeds.2004.01.046_BIB30","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1056\/NEJMoa012212","article-title":"Bosentan therapy for pulmonary arterial hypertension","volume":"346","author":"Rubin","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jpeds.2004.01.046_BIB31","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1056\/NEJM199602013340504","article-title":"A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension: the Primary Pulmonary Hypertension Study Group","volume":"334","author":"Barst","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jpeds.2004.01.046_BIB32","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1056\/NEJMoa020204","article-title":"Inhaled iloprost for severe pulmonary hypertension","volume":"347","author":"Olschewski","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jpeds.2004.01.046_BIB33","first-page":"586A","article-title":"Rationale and development of a functional disability outcomes measure for MPS I","volume":"71","author":"Skrinar","year":"2002","journal-title":"Am J Hum Genet"}],"container-title":["The Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022347604000915?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022347604000915?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,2]],"date-time":"2020-04-02T03:58:19Z","timestamp":1585799899000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022347604000915"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,5]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2004,5]]}},"alternative-id":["S0022347604000915"],"URL":"https:\/\/doi.org\/10.1016\/j.jpeds.2004.01.046","relation":{},"ISSN":["0022-3476"],"issn-type":[{"value":"0022-3476","type":"print"}],"subject":[],"published":{"date-parts":[[2004,5]]}}}